Inflammatory and fibrinolytic states in cats with and without cardiogenic atrial/arterial thromboembolism stratified by the presence and type of congestive heart failure
Journal of Small Animal Practice · 2026
DOI: 10.1111/jsap.70007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Small Animal Practice, 2026. Verfasst von F Busato und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Internal Medicine, San Marco Veterinary Clinic, Padua, Italy. Hauptthemen laut MEDLINE: Cat Diseases, Heart Failure, Thromboembolism, Pleural Effusion. Die Arbeit nennt 44 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Objective
To assess whether cats with cardiogenic pleural effusion have less systemic inflammation or an enhanced systemic fibrinolysis, preventing cardiogenic atrial/arterial thromboembolism compared to cats with cardiac disease without pleural effusion. Materials and Methods Cross‐sectional study evaluating cats presented with cardiac disease: without congestive heart failure ( n = 246), with cardiogenic pulmonary oedema (49) and with cardiogenic pleural effusion (94). At presentation, plasma fibrinogen and serum amyloid A were measured, and the fibrinogen:serum amyloid A (a marker of systemic fibrinolysis) was calculated. The frequency of cardiogenic atrial/arterial thromboembolism among groups was compared using the chi‐squared test, whereas the other biomarkers were analysed using non‐parametric tests.
Results
The prevalence of cardiogenic atrial/arterial thromboembolism was significantly higher in cats with pulmonary oedema (18/49, 36.7%) compared with cats without congestive heart failure (23/246, 9.3%) and with cardiogenic pleural effusion (9/94, 9.6%). The median serum amyloid A concentration in cats with cardiogenic pleural effusion (3.35 mg/L) was significantly higher than that in cats without congestive heart failure (0.65 mg/L), whereas no significant differences were found between cats with pulmonary oedema (1.4 mg/L) and those with pleural effusion or without congestive heart failure. After excluding 50 cats with cardiogenic atrial/arterial thromboembolism, there were 223 cats without congestive heart failure, 31 with pulmonary oedema, and 85 with pleural effusion. In the 85 cats without cardiogenic atrial/arterial thromboembolism and with cardiogenic pleural effusion, the median fibrinogen:serum amyloid A ratio (58) was significantly lower than the fibrinogen:serum amyloid A ratio (316) observed in the remaining 254 cats without cardiogenic atrial/arterial thromboembolism from the other two groups combined. Clinical Significance Enhanced systemic fibrinolysis may play a role in the lower cardiogenic atrial/arterial thromboembolism risk of cats with cardiogenic pleural effusion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Internal Medicine, San Marco Veterinary Clinic, Padua, Italy.
- Department of Animal Medicine, Production and Health, University of Padua, Padua, Italy.
Zitieren
APA
Busato, F., Drigo, M., & Zoia, A. (2026). Inflammatory and fibrinolytic states in cats with and without cardiogenic atrial/arterial thromboembolism stratified by the presence and type of congestive heart failure. Journal of Small Animal Practice. https://doi.org/10.1111/jsap.70007
Vancouver
Busato F, Drigo M, Zoia A. Inflammatory and fibrinolytic states in cats with and without cardiogenic atrial/arterial thromboembolism stratified by the presence and type of congestive heart failure. Journal of Small Animal Practice. 2026. doi:10.1111/jsap.70007
BibTeX
@article{Busato2026,
author = {Busato, F and Drigo, M and Zoia, A},
title = {Inflammatory and fibrinolytic states in cats with and without cardiogenic atrial/arterial thromboembolism stratified by the presence and type of congestive heart failure},
journal = {Journal of Small Animal Practice},
year = {2026},
doi = {10.1111/jsap.70007}
}
EUVIMED